Assessing caffeine exposure in pregnant women

British Journal of Nutrition

Volumn 100, Issue 4, 2008, Pages 875-882

  Boylan, Sinead M ^a   Cade, Janet E ^a   Kirk, Sara F L ^a   Greenwood, Darren C ^a   White, Kay I M ^a   Shires, Susan ^a   Simpson, Nigel A B ^b   Wild, Chris P ^a   Hay, Alastair W M ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Assessment; Caffeine; Pregnancy

Indexed keywords

CAFFEINE; PARAXANTHINE;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIETARY INTAKE; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL NUTRITION; NUTRITIONAL ASSESSMENT; PREGNANCY OUTCOME; PREGNANT WOMAN; QUESTIONNAIRE; SALIVA ANALYSIS; UNITED KINGDOM;

ADULT; BIOLOGICAL MARKERS; CAFFEINE; DIET RECORDS; FEMALE; FOOD HABITS; HUMANS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTERS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SALIVA; SENSITIVITY AND SPECIFICITY; THEOPHYLLINE;

EID: 51749091104     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114508939842     Document Type: Article

References (35)

1. Durrant KL (2002) Known and hidden sources of caffeine in drug, food, and natural products. J Am Pharm Assoc 42, 625-637.
2. Nishimura H & Nakai K (1960) Congenital malformations in offspring of mice treated with caffeine. Proc Soc Exp Biol Med 104, 140-142.
3. Committee on Toxicity of Chemicals in Foods, Consumer Products and the Environment (COT) (2001) Statement on the Reproductive Effects of Caffeine. London: Food Standards Agency.
4. Beaulac-Baillargeon L & Desrosiers C (1987) Caffeine-cigarette interaction on fetal growth. Am J Obstet Gynecol 157, 1236-1240.
5. Martin TR & Bracken MB (1987) The association between low birth weight and caffeine consumption during pregnancy. Am J Epidemiol 126 813-821.
6. Vlajinac HD, Petrovic RR, Marinkovic JM, Sipetic SB & Adanja BJ (1997) Effect of caffeine intake during pregnancy on birth weight. Am J Epidemiol 145, 335-338.
7. Barr HM & Streissguth AP (1991) Caffeine use during pregnancy and child outcome: A 7-year prospective study. Neurotoxicol Teratol 13 441-448.
8. Godel JC, Pabst HP, Hodges PE, Johnson KF, Froese GJ & Joffres MR (1992) Smoking and caffeine and alcohol intake during pregnancy in a northern population: Effect on fetal growth. CMAJ 147, 181-188.
9. Santos IS, Victora CG, Huttly S & Carvalhal JB (1998) Caffeine intake and low birth weight: A population-based case-control study. Am J Epidemiol 147, 620-627.
10. Clausson B, Granath F, Ekbom A, Lundgren S, Nordmark A, Signorello LB & Cnattingius S (2002) Effect of caffeine exposure during pregnancy on birth weight and gestational age. Am J Epidemiol 155, 429-436.
11. Linn S, Schoenbaum SC, Monson RR, Rosner B, Stubblefield PG & Ryan KJ (1982) No association between coffee consumption and adverse outcomes of pregnancy. N Engl J Med 306, 141-145.
12. Mau G & Netter P (1974) Are coffee and alcohol consumption risk factors in pregnancy? (article in German). Geburtshilfe Frauenheilkd 34 1018-1022.
13. McDonald AD, Armstrong BG & Sloan M (1992) Cigarette, alcohol, and coffee consumption and prematurity. Am J Public Health 82, 87-90.
14. Klebanoff MA, Levine RJ, DerSimonian R, Clemens JD & Wilkins DG (1998) Serum caffeine and paraxanthine as markers for reported caffeine intake in pregnancy. Ann Epidemiol 8, 107-111.
15. Danhof M & Breimer DD (1978) Therapeutic drug monitoring in saliva. Clin Pharmacokinet 3, 39-57.
16. Horning MG, Brown L, Nowlin J, Lertratanangkoon K, Kellaway P & Zion TE (1977) Use of saliva in therapeutic drug monitoring. Clin Chem 23, 157-164.
17. James JE, Bruce MS, Lader MH & Scott NR (1989) Self-report reliability and symptomatology of habitual caffeine consumption. Br J Clin Pharmacol 27, 507-514.
18. Murray S, Lake BG, Gray S, Edwards AJ, Springall C, Bowey EA, Williamson G, Boobis AR & Gooderham NJ (2001) Effect of cruciferous vegetable consumption on heterocyclic aromatic amine metabolism in man. Carcinogenesis 22, 1413-1420.
19. Fuhr U, Klittich K & Staib AH (1993) Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. Br J Clin Pharmacol 35, 431-436.
20. Fontana RJ, Lown KS, Paine MF, Fortlage L, Santella RM, Felton JS, Knize MG, Greenberg A & Watkins PB (1999) Effects of a chargrilled meat diet on expression of CYP3A, CYPlA, and P-glycoprotein levels in healthy volunteers. Gastroenterology 117, 89-98.
21. Ministry of Agriculture, Fisheries and Food - Food Safety Directorate (1998) Survey of Caffeine and Other Methylxanthines in Energy Drinks and Other Caffeine-Containing Products (updated). 144. Food Survellance Information Sheet. London: MAFF.
22. Butler MA, Lang NP, Young JF, Caparaso NE, Vineis P, Hayes RB, Teitel CH, Massengill JP, Lawsen MF & Kadlubar FF (1992) Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics 2, 116-127.
23. Rasbash J, Browne W & Goldstein H (2091) A User's Guide to MLwIN. London: University of London.
24. Office for National Statistics (2002) The National Statistics Socio-Economic Classification User Manual, 1st ed. London: HM Stationery Office.
25. Barone JJ & Roberts HR (1996) Caffeine consumption. Food Chem Toxicol 34, 119-129.
26. Butler MA, Iwasaki M, Guengerich FP & Kadlubar FF (1989) Human cytochrome P-450PA (P-4501A2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci U S A 86, 7696-7700.
27. Zaigler M, Rietbrock S, Szymanski J, Dericks-Tan JSE, Staib AH & Fuhr U (2000) Variation of CYP1A2-dependent caffeine metabolism during menstrual cycle in healthy women. Int J Clin Pharmacol Ther 38 235-244.
28. Andersen MR, Farin FM & Omiecinaki CJ (1998) Quantification of multiple human cytochrome P450mRNA molecules using competitive reverse transcriptase-PCR. DNA Cell Biol 17, 231-238.
29. Finnstrom N, Thorn M, Loof L & Rane A (2001) Independent patterns of cytochrome P450 gene expression in liver and blood in patients with suspected liver disease. Eur J Clin Pharmacol 57, 403-409.
30. Vineis P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J & Boffetta P (1999) Metabolic Polymorphisms and Susceptibility to Cancer. Lyon: International Agency for Research on Cancer.
31. Carrillo JA, Christensen M, Ramos SI, et al. (2000) Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma saliva, and urine. Ther Drueg Monit 22, 409-417.
32. Newton R, Broughton LJ, Lind MJ, Morrison PJ, Rogers HJ & Bradbrook ID (1981) Plasma and salivary pharmacokinetics of caffeine in man. Eur J Clin Pharmacol 21, 45-52.
33. Notarianni LJ, Oliver SE, Dobrocky P, Bennett PN & Silverman BW (1995) Caffeine as a metabolic probe: A comparison of the metabolic ratios used to assess CYP1A2 activity. Br J Clin Pharmacol 39, 65-69.
34. Bracken MB, Triche E, Grosso L, Hellenbrand K, Belanger K & Leaderer BP (2002) Heterogeneity in assessing self-reports of caffeine exposure: implications for studies of health effects. Epidemiology 13, 165-171.
35. Aldridge A, Bailey J & Neims AH (1991) The disposition of caffeine during and after pregnancy. Semin Perinatol 5, 310-314.